• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Kenya Pharmaceuticals and Healthcare Report Q1 2012 - Product Image

Kenya Pharmaceuticals and Healthcare Report Q1 2012

  • Published: November 2011
  • Region: Kenya
  • 97 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Dawa Limited
  • GlaxoSmithKline
  • High Chem East Africa
  • Indigenous Producers
  • Merck & Co
  • Novartis
  • MORE

Business Monitor International's Kenya Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Kenya's pharmaceuticals and healthcare industry.

BMI View: The Kenyan pharmaceuticals and healthcare market presents significant revenue earning opportunities for drug companies. Growth in the sector will be boosted by strong demographics, increased healthcare needs, longer life expectancy, rising healthcare spending in the public and private sectors and improved access to health facilities. Furthermore, in addition to an increase in the healthcare services provided by the government, BMI notes that there is also a growing demand for health services due to a growing awareness of preventative healthcare.

Headline Expenditure Projections

- Pharmaceuticals: KES33.02bn (US$417mn) in 2010 to KES38.72bn (US$450mn) in 2011; +17.3% growth in local currency terms and +5.6% in US dollar terms.

- Healthcare: KES146.71bn (US$ 1.85bn) in 2010 to KES167.43bn (US$1.90bn) in 2011; 14.1% growth in READ MORE >

Executive Summary

SWOT Analysis
Kenya Pharmaceuticals And Healthcare Industry SWOT
Kenya Political SWOT
Kenya Economic SWOT
Kenya Business Environment SWOT

Pharmaceutical Business Environment Ratings
Table: Middle East And Africa Pharmaceutical Business Environment Ratings, Q112
Rewards
Risks

Kenya – Market Summary

Regulatory Regime
Counterfeit Drugs
Intellectual Property
Pricing And Reimbursement Regime
Table: Kenya Medical Supply Agency Mandate

Industry Trends and Developments
Epidemiology
Healthcare Provision
Healthcare Sector Financing
Health Insurance
Private Healthcare
National Drug Policy
Supply Chain
Medical Devices
Clinical Trials

Industry Forecast Scenario
Overall Market Forecast
Table: Kenya – Pharmaceutical Sales, Historical Data and Forecast, 2007-2016
Key Growth Factors – Industry
Table: Kenya – Healthcare, Historical Data and Forecast, 2007-2016
Key Growth Factors – Macroeconomic
Table: Kenya – Economic Activity
Prescription Drug Market Forecast
Table: Kenya – Pharmaceutical Prescription Drug Sales, Historical Data and Forecast, 2007-2016
Patented Drug Market Forecast
Table: Kenya – Pharmaceutical Patented Drug Sales, Historical Data and Forecast, 2007-2016
Generic Drug Market Forecast
Table: Kenya – Pharmaceutical Generic Drug Sales, Historical Data and Forecast, 2007-2016
OTC Medicine Market Forecast
Table: Kenya – Pharmaceutical OTC Medicine Sales, Historical Data and Forecast, 2007-2016
Medical Device Market Forecast
Table: Kenya – Medical Device Sales, Historical Data and Forecast, 2007-2016
Pharmaceutical Trade Forecast
Table: Kenya – Pharmaceuticals, Historical Data and Forecast, 2007-2016
Other Healthcare Data Forecasts
Key Risks To BMI’s Forecasts

Competitive Landscape
Pharmaceutical Industry Activities

Company Profiles
Multinationals
GlaxoSmithKline
Pfizer
Novartis
Sanofi-Aventis
Merck & Co
Indigenous Producers
Dawa Limited
Universal Corporation Limited
Shelys Pharmaceuticals
Regal Pharmaceuticals
High Chem East Africa

Country Snapshot: Kenya Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2002-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Consumer Expenditure, 2000-2012 (US$)

Glossary

BMI Methodology
How We Generate Our Pharmaceutical Industry Forecasts

Pharmaceuticals Business Environment Ratings
Risk/Reward Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- GlaxoSmithKline
- Pfizer
- Novartis
- Sanofi-Aventis
- Merck & Co
- Indigenous Producers
- Dawa Limited
- Universal Corporation Limited
- Shelys Pharmaceuticals
- Regal Pharmaceuticals
- High Chem East Africa

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos